Antibodies are forever: A study using 12-26-year-old expired antibodies

Histopathology

Volumn 63, Issue 6, 2013, Pages 869-876

  Argentieri, Maria C ^a   Pilla, Daniela ^a   Vanzati, Alice ^a,b   Lonardi, Silvia ^c   Facchetti, Fabio ^c   Doglioni, Claudio ^d   Parravicini, Carlo ^e   Cattoretti, Giorgio ^a,b  

^a AO San Gerardo ^*  (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Antibody; Expiry date; Immunohistochemistry

Indexed keywords

ALPHA ACTIN; ANTIBODY; BNH9 ANTIBODY; CD3 ANTIGEN; CD34 ANTIBODY; CD45 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD74 ANTIGEN; CD79A ANTIGEN; CYCLINE; CYTOKERATIN 19; HMFG2 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; INSULIN ANTIBODY; KERATIN ANTIBODY; KI 67 ANTIGEN; LEUKOCYTE ELASTASE; MAC387 ANTIBODY; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN P53; PROTEIN S 100; UNCLASSIFIED DRUG;

ARTICLE; EXPIRATION DATE; HALF LIFE TIME; HISTOLOGY; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SHELF LIFE;

ANTIBODY; EXPIRY DATE; IMMUNOHISTOCHEMISTRY;

ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; DRUG STORAGE; FREEZING; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEIN STABILITY; TIME FACTORS;

EID: 84887819236     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12225     Document Type: Article

References (31)

1. Hammond MEH, Hayes DF, Dowsett M et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch. Pathol. Lab. Med. 2010; 134; e48-e72.
2. Wang W, Singh S, Zeng DL, King K, Nema S. Antibody structure, instability, and formulation. J. Pharm. Sci. 2007; 96; 1-26.
3. Savage EC, DeYoung BR. Antibody expiration in the context of resource limitation: what is the evidence basis? Am. J. Clin. Pathol. 2010; 134; 60-64.
4. Balaton AJ, Drachenberg CB, Rucker CHT, Vaury P, Papadimitriou JC. Satisfactory performance of primary antibodies beyond manufacturers' recommended expiration dates. Appl. Immunohistochem. Mol. Morphol. 1999; 7; 221-225.
5. Tubbs RR, Nagle R, Leslie K et al. Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists. Arch. Pathol. Lab. Med. 1998; 122; 1051-1052.
6. Vigliani R, Babache N. Primary antisera before and after the expiration date. Comparative immunohistochemical observations and analysis of data sheets and labels. Pathologica 2002; 94; 121-129.
7. Spira G, Gregor P, Aguila HL, Scharff MD. Clonal variants of hybridoma cells that switch isotype at a high frequency. Proc. Natl Acad. Sci. USA 1994; 91; 3423-3427.
8. Kubbutat MH, Key G, Duchrow M, Schlüter C, Flad HD, Gerdes J. Epitope analysis of antibodies recognising the cell proliferation associated nuclear antigen previously defined by the antibody Ki-67 (ki-67 protein). J. Clin. Pathol. 1994; 47; 524-528.
9. Friboulet L, Olaussen KA, Pignon J-P et al. Ercc1 isoform expression and DNA repair in non-small-cell lung cancer. N. Engl. J. Med. 2013; 368; 1101-1110.
10. Rimm DL. What brown cannot do for you. Nat. Biotechnol. 2006; 24; 914-916.
11. Wang W, Wang YJ, Wang DQ. Dual effects of tween 80 on protein stability. Int. J. Pharm. 2008; 347; 31-38.
12. Cattoretti G, Pileri S, Parravicini C et al. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J. Pathol. 1993; 171; 83-98.
13. Kent UM. Purification of antibodies using ammonium sulfate fractionation or gel filtration. Methods Mol. Biol. 1999; 115; 11-18.
14. Weser U, Etspuler H, Kaup Y. Enzymatic and immunological activity of 4000 years aged bone alkaline phosphatase. FEBS Lett. 1995; 375; 280-282.
15. Xie R, Chung J-Y, Ylaya K et al. Factors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections. J. Histochem. Cytochem. 2011; 59; 356-365.
16. Chan R, Edwards BF, Hu R et al. Characterization of two monoclonal antibodies in an immunohistochemical study of keratin 8 and 18 expression. Am. J. Clin. Pathol. 1988; 89; 472-480.
17. Woodcock-Mitchell J, Eichner R, Nelson WG, Sun TT. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J. Cell Biol. 1982; 95; 580-588.
18. Banks L, Matlashewski G, Crawford L. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur. J. Biochem. 1986; 159; 529-534.
19. Cattoretti G, Rilke F, Andreola S, D'Amato L, Delia D. P53 expression in breast cancer. Int. J. Cancer 1988; 41; 178-183.
20. Ledbetter JA, Rose LM, Spooner CE, Beatty PG, Martin PJ, Clark EA. Antibodies to common leukocyte antigen p220 influence human T cell proliferation by modifying IL 2 receptor expression. J. Immunol. 1985; 135; 1819-1825.
21. Young JW, Koulova L, Soergel SA, Clark EA, Steinman RM, Dupont B. The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4 + T lymphocytes by human blood dendritic cells in vitro. J. Clin. Invest. 1992; 90; 229-237.
22. Tenner-Racz K, Racz P, Dietrich M et al. Monoclonal antibodies to human immunodeficiency virus: their relation to the patterns of lymph node changes in persistent generalized lymphadenopathy and aids. AIDS 1987; 1; 95-104.
23. Radzun HJ, Hansmann ML, Heidebrecht HJ et al. Detection of a monocyte/macrophage differentiation antigen in routinely processed paraffin-embedded tissues by monoclonal antibody Ki-M1p. Lab. Invest. 1991; 65; 306-315.
24. Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J. 1990; 9; 1595-1602.
25. West KP, Warford A, Fray L, Allen M, Campbell AC, Lauder I. The demonstration of B-cell, T-cell and myeloid antigens in paraffin sections. J. Pathol. 1986; 150; 89-101.
26. Poppema S, Lai R, Visser L. Monoclonal antibody OPd4 is reactive with CD45R0, but differs from UCHL1 by the absence of monocyte reactivity. Am. J. Pathol. 1991; 139; 725-729.
27. Flavell DJ, Jones DB, Wright DH. Identification of tissue histiocytes on paraffin sections by a new monoclonal antibody. J. Histochem. Cytochem. 1987; 35; 1217-1226.
28. Pulford KA, Erber WN, Crick JA et al. Use of monoclonal antibody against human neutrophil elastase in normal and leukaemic myeloid cells. J. Clin. Pathol. 1988; 41; 853-860.
29. Sano K, Sekine J, Inokuchi T, Pe MB, Ma G. Enhanced polymer one-step staining for proliferating cell nuclear antigen in squamous cell carcinoma of the tongue. Biotech. Histochem. 1996; 71; 273-277.
30. Delsol G, Blancher A, al Saati T et al. Antibody BNH9 detects red blood cell-related antigens on anaplastic large cell (CD30 + ) lymphomas. Br. J. Cancer 1991; 64; 321-326.
31. Norton AJ, Isaacson PG. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue. Am. J. Pathol. 1987; 128; 225-240.